Karin M. Guirguis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Karin M. Guirguis has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Tarek Saied Belal
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy Alexandria University Alexandria Egypt
3 shared publications A. A. Gazy
1 shared publicationAmira F. El-Yazbi
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, University of Alexandria, Elmessalah, 21521, Alexandria, Egypt
1 shared publication- Amira F. El-Yazbi
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
1 shared publication M. M. Bedair
1 shared publication- Miranda Fawzy Kamal
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt
1 shared publication
Latest Publications
- 4 March 2022
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 105 (4) , 972-978
Simultaneous Quantitation of Paracetamol and Lornoxicam in the Presence of Five Related Substances and Toxic Impurities by a Selective HPLC–DAD Method
This research describes the simultaneous quantitation of Paracetamol (PRM) and Lornoxicam (LRX) with five of their related substances and toxic impurities, including, 4-nitrophenol (NTP), 4-aminophenol (AMP), 4-chloroacetanilide (CAC), N-phenylacetamide (NPA), and 2-aminopyridine (APD) using a specific HPLC-DAD method. The chromatographic separation involves the use of XTerra C18 column as the stationary phase and a mobile phase consisting of acetonitrile and 0.025 M phosphate buffer (pH 6). The separation was performed using gradient elution mode at 1.0 mL min−1 flow rate and detection at 260 nm for the determination of PRM and LRX. While for detecting PRM, LRX in presence of their toxic impurities, 270 nm was convenient. Validation of the suggested HPLC method was accomplished in regards to linearity, ranges, detection and quantitation limits, robustness, accuracy, precision and specificity. Excellent resolution of the mixture components was accomplished at retention times 4.2, 4.8, 7.4, 11.1, 13.5, 14.7 and 15.3 min for APD, AMP, PRM, NPA, LRX, NTP and CAC, respectively. Linearity was established for PRM and LRX within concentration ranges of 10–100 and 10–60 µg/mL, respectively. The correlation coefficients obtained were > 0.9997. The suggested method was confirmed to be a specific stability-indicating through the selective separation of PRM and LRX from their related substances, degradants and impurities. The proposed method was successfully utilized for the sensitive and selective determination of PRM and LRX in their pharmaceutical formulation. To the best of our knowledge, this is the first impurity profiling assay method for this combination in presence of five of their toxic related substances and impurities. Taking into consideration that at least 2 of the studied impurities (AMP and APD) are actually reported degradation products for the main drugs, therefore the suggested method can be considered stability-indicating as well.
- 4 March 2022
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 105 (4) , 972-978
Simultaneous Quantitation of Paracetamol and Lornoxicam in the Presence of Five Related Substances and Toxic Impurities by a Selective HPLC–DAD Method
This research describes the simultaneous quantitation of Paracetamol (PRM) and Lornoxicam (LRX) with five of their related substances and toxic impurities, including, 4-nitrophenol (NTP), 4-aminophenol (AMP), 4-chloroacetanilide (CAC), N-phenylacetamide (NPA), and 2-aminopyridine (APD) using a specific HPLC-DAD method. The chromatographic separation involves the use of XTerra C18 column as the stationary phase and a mobile phase consisting of acetonitrile and 0.025 M phosphate buffer (pH 6). The separation was performed using gradient elution mode at 1.0 mL min−1 flow rate and detection at 260 nm for the determination of PRM and LRX. While for detecting PRM, LRX in presence of their toxic impurities, 270 nm was convenient. Validation of the suggested HPLC method was accomplished in regards to linearity, ranges, detection and quantitation limits, robustness, accuracy, precision and specificity. Excellent resolution of the mixture components was accomplished at retention times 4.2, 4.8, 7.4, 11.1, 13.5, 14.7 and 15.3 min for APD, AMP, PRM, NPA, LRX, NTP and CAC, respectively. Linearity was established for PRM and LRX within concentration ranges of 10–100 and 10–60 µg/mL, respectively. The correlation coefficients obtained were > 0.9997. The suggested method was confirmed to be a specific stability-indicating through the selective separation of PRM and LRX from their related substances, degradants and impurities. The proposed method was successfully utilized for the sensitive and selective determination of PRM and LRX in their pharmaceutical formulation. To the best of our knowledge, this is the first impurity profiling assay method for this combination in presence of five of their toxic related substances and impurities. Taking into consideration that at least 2 of the studied impurities (AMP and APD) are actually reported degradation products for the main drugs, therefore the suggested method can be considered stability-indicating as well.
- Open Access
Simple mix-and-read assays for the determination of baclofen in pharmaceutical formulation
- Open Access
- 1 September 2015
- Published by Akademiai Kiado Zrt. in Acta Chromatographica
- Vol. 27 (3) , 477-493
Validated Selective HPLC-DAD Method for the Simultaneous Determination of Diclofenac Sodium and Lidocaine Hydrochloride in Presence of Four of Their Related Substances and Potential Impurities
This study presents a selective high-performance liquid chromatography (HPLC) with diode array detection (DAD) method for the simultaneous estimation of diclofenac sodium and lidocaine hydrochlorid...
- 1 September 2015
- Published by Akademiai Kiado Zrt. in Acta Chromatographica
- Vol. 27 (3) , 477-493
Open AccessValidated Selective HPLC-DAD Method for the Simultaneous Determination of Diclofenac Sodium and Lidocaine Hydrochloride in Presence of Four of Their Related Substances and Potential Impurities
This study presents a selective high-performance liquid chromatography (HPLC) with diode array detection (DAD) method for the simultaneous estimation of diclofenac sodium and lidocaine hydrochlorid...